Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorf Laboratories, AI Medication Discovery Platform Bend Google’s Doepmind For the first time in 2021, he raised foreign capital. The 600-million dollar tour, GV and existing investor alphabet, Google’s parent, the capital of the existing investor alphabet was headed by the capital. We said.

The Financing Isomorphi will accelerate the further development of the AI ​​medicinal design engine and support the purpose of bringing the company discovered drugs to clinical trials.

Isomorphic laboratories, DEEPMind co-founder Demis Hassabis, including AI medicinal discoveries, including AI Model, the AI ​​model, which is an AI model that predicts three-dimensional structures of proteins, was established.

Last year, Isomorphic Laboratories with Eli Lilly and Novartis, potentially provided strategic partnership To create up to $ 3 billion Payments in stage to access its AI model.

Hassabis said New York Times When Isomorphic Laboratories do not need to capital, additional financing division will help you hire the best research scientists.

Alphafold, Hassabis and Deepmind researcher John Jumper’s work was among the three scientists who received Nobel Prize in Chemistry In 2024.